UPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors

Stem Cell Research

Volumn 12, Issue 1, 2014, Pages 1-10

  Sobrevals, Luciano ^a,b   Mato Berciano, Ana ^a,b   Urtasun, Nerea ^c,d   Mazo, Adela ^c,d   Fillat, Cristina ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; GEMCITABINE; ONCOLYTIC ADENOVIRUS; SODIUM CHLORIDE;

ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STEM CELL; CASE REPORT; CELL POPULATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; SINGLE DRUG DOSE; XENOGRAFT;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; CELL ADHESION MOLECULES; DEOXYCYTIDINE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; ONCOLYTIC VIROTHERAPY; PANCREATIC NEOPLASMS; PEPTIDES; PROMOTER REGIONS, GENETIC; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84885969809     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.09.008     Document Type: Article

References (31)

1. Aghi M., Martuza R.L. Oncolytic viral therapies - the clinical experience. Oncogene 2005, 24:7802-7816.
2. Alemany R., Curiel D.T. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 2001, 8:1347-1353.
3. Alonso M.M., et al. Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol. Biol. 2012, 797:111-125.
4. Asuthkar S., et al. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/beta-catenin signaling is enhanced in irradiated medulloblastoma cells. J. Biol. Chem. 2012, 287:20576-20589.
5. Balic A., et al. Stem cells as the root of pancreatic ductal adenocarcinoma. Exp. Cell Res. 2012, 318:691-704.
6. -/low breast cancer cells. Cancer Res. 2008, 68:5533-5539.
7. Bednar F., Simeone D.M. Pancreatic cancer stem cells and relevance to cancer treatments. J. Cell. Biochem. 2009, 107:40-45.
8. Cascante A., et al. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model. Gene Ther. 2007, 14:1471-1480.
9. -/low cells. Mol. Ther. 2007, 15:2088-2093.
10. Fillat C., et al. Controlling adenoviral replication to induce oncolytic efficacy. Open Gene Ther. J. 2010, 3:15-23.
11. Friedman G.K., et al. Targeting pediatric cancer stem cells with oncolytic virotherapy. Pediatr. Res. 2012, 71:500-510.
12. Gopinath S., et al. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression. Carcinogenesis 2013, 34:550-559.
13. Gutova M., et al. Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One 2007, 2:e243.
14. Hermann P.C., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
15. Hindriksen S., Bijlsma M.F. Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors. Cancers 2012, 4:985-1035.
16. Huch M., et al. Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models. Neoplasia 2009, 11:518-528.
17. Jiang H., et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J. Natl. Cancer Inst. 2007, 99:1410-1414.
18. Jiang H., et al. Adenovirus's last trick: you say lysis, we say autophagy. Autophagy 2008, 4:118-120.
19. Jo M., et al. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Cancer Res. 2010, 70:8948-8958.
20. Jose A., et al. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett. 2012, 317:16-23.
21. Kern S.E., et al. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. J. Pathol. 2011, 223:295-306.
22. Kim M.P., et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat. Protoc. 2009, 4:1670-1680.
23. Li C., et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
24. Li C., et al. Identification of human pancreatic cancer stem cells. Methods Mol. Biol. 2009, 568:161-173.
25. Lonardo E., et al. Nodal/activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 2011, 9:433-446.
26. Mueller M.T., et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009, 137:1102-1113.
27. Perez-Torras S., et al. Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening. Cell. Oncol. (Dordr.) 2011, 34:511-521.
28. Qiu X., et al. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. 2012, 323:161-170.
29. Rasheed Z.A., et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J. Natl. Cancer Inst. 2010, 102:340-351.
30. Short J.J., Curiel D.T. Oncolytic adenoviruses targeted to cancer stem cells. Mol. Cancer Ther. 2009, 8:2096-2102.
31. Venkatesha V.A., et al. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia 2012, 14:519-525.